Results 51 to 60 of about 13,620 (98)

Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target. [PDF]

Prostate
Luk JTF, Lin AH, Cheung EKC, Meçani R, Muka T, Nano J, Ng JKM, Chiu MKL, Li BCW, Na R, Li JJX.   +10 more
europepmc   +1 more source

Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients with Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase Studies. [PDF]

Clin Cancer Res
Lee KW, Elimova E, Oh DY, Beeram M, Doi T, Yeung KT, Samuel Nached T, Shah KV, Fuller DS, Shpektor D, Loro E, Meric-Bernstam F.   +11 more
europepmc   +1 more source

Phosphatase Signaling as a Therapeutic Strategy in Schizophrenia. [PDF]

Int J Mol Sci
Molony LE, Tautz L.
europepmc   +1 more source

Regional Variations in Guideline Concordance for Women with Triple-Negative and HER2+ Breast Cancer in Nova Scotia. [PDF]

Curr Oncol
Mayo A, Stewart H, Li T, Penny C, Hemsworth R, Drohan A, Neumann K, Gala-Lopez B, Spence RT, Knapp G.   +9 more
europepmc   +1 more source

Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysis. [PDF]

Breast
Yang Y, Pan L, Zhou W, Shao Z.
europepmc   +1 more source

Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. [PDF]

Target Oncol
Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, Le X.   +6 more
europepmc   +1 more source

X-ray crystal structure and in silico investigation of Tetrabromo thia-bridged diquinoline including anticancer mechanisms via target prediction and molecular docking. [PDF]

Sci Rep
Alshahateet SF, Al-Mazaideh GM, Al-Trawneh SA, Al-Taweel SA, Jodeh S.   +4 more
europepmc   +1 more source

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Yamaguchi Y, Hoshino M, Shimoi T, Tamura H, Natori Y, Saiki T, Yamanaka T, Kitadai R, Saito A, Kita S, Maejima A, Kojima Y, Sudo K, Maeshima AM, Murata T, Takayama S, Naoi Y, Yonemori K, Yoshida M.   +18 more
europepmc   +1 more source

Premenopausal Patients With Clinically Aggressive Metastatic Breast Cancer Successfully Treated With a First-Line Palbociclib-Containing Regimen: Two Cases and Literature Review. [PDF]

Cancer Rep (Hoboken)
Fu PA, Hsu YC, Hsu HP, Lin TC, Chung WP.
europepmc   +1 more source

HScore as a diagnostic tool in ERBB2 equivocal (immunohistochemistry 2+) breast cancer. [PDF]

Lab Med
Alsebai T, Swied MY, Cossyleon R, Robinson K, Delfino K, Gao J, Rao K.   +6 more
europepmc   +1 more source